Maternal obesity is associated with phenotypic alterations in fetal immune cells by single‐cell mass cytometry

• Published in: American journal of reproductive immunology (1989) Vol. 85; no. 3; pp. e13358 - n/a
• Main Authors: Enninga, Elizabeth Ann L., Jang, Jin Sung, Hur, Benjamin, Johnson, Erica L., Wick, Myra J., Sung, Jaeyun, Chakraborty, Rana
• Format: Journal Article
• Language: English
• Published: Denmark Wiley Subscription Services, Inc 01.03.2021
• Subjects: Body mass index; CD4 antigen; Cord blood; Cytometry; Fetuses; Gestational age; immunity; Infants; Leukocytes (mononuclear); Lymphocytes T; mass cytometry; Obesity; Phenotypes; Prenatal experience; Prenatal exposure; cord blood; immunity; mass cytometry; body mass index
• ISSN: 1046-7408; 1600-0897; 1600-0897
• DOI: 10.1111/aji.13358

Problem Prenatal exposure to metabolic dysregulation arising from maternal obesity can have negative health consequences in post‐natal life. To date, the specific effects of maternal obesity on fetal immunity at a cellular level have not been well characterized. Method of Study Using cord blood mononuclear cells (CBMCs) and cord plasma (n = 9/group) isolated from infants born to women with a high body mass index (BMI>25kg/m2) compared to women with a normal BMI (18‐25kg/m2), we evaluated differences in immune cell populations using single‐cell mass cytometry (CyTOF). CBMCs were matched according to potentially confounding variables, such as maternal and gestational age, ethnicity, smoking status, and gravidity. Statistical results were adjusted for fetal sex. Data were analyzed by viSNE and FlowSOM softwares in Cytobank™. Results In newborn CBMCs from women with high BMI, we observed changes in frequency and phenotype of immune cell populations, including significant increases in CD4+ T cells and decreases in myeloid cell populations. IL‐12p40 and MDC concentrations were significantly elevated in the high BMI group compared to control. Conclusion This study demonstrates an association between maternal obesity and fetal immunity. Our results warrant following long‐term immunologic outcomes and associated clinical risks in children born to women with a high pre‐pregnancy BMI.